Promega Sues Roche, Alleging Overcharging Scheme for Taq Polymerase

Nov 13, 2003

NEW YORK, Nov. 13 (GenomeWeb News) - Promega has sued Hoffman-La Roche under the US False Claims act, alleging that Roche overcharged the US government and its agencies by reuiring royalty payments for research using the Taq DNA polymerase, Promega said late today.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Marks Left on the Genome

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

Mosquito Population Crash

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

Cost and Coverage of Gene Therapies

The Wall Street Journal looks into the cost of new gene therapies.

This Week in PNAS

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.

Main menu